Dragon Images / Shutterstock.com
2 July 2019Biotechnology
Carpmaels & Ransford name two new partners
Carpmaels & Ransford has appointed two life sciences attorneys as partners, effective yesterday, July 1.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Big Pharma
9 February 2016 Law firm Carpmaels & Ransford has hired David Wilson and Jake Marshall as partners in the firm’s patent litigation and life sciences practices.
Big Pharma
25 June 2018 Carpmaels & Ransford has added two life sciences lawyers to its partnership, effective from July 1.
Big Pharma
1 September 2022 New partner brings pharma and chemistry focus, and boosts the European firm’s Unified Patent Court team.
Editor's picks
Editor's picks
Big Pharma
9 February 2016 Law firm Carpmaels & Ransford has hired David Wilson and Jake Marshall as partners in the firm’s patent litigation and life sciences practices.
Big Pharma
25 June 2018 Carpmaels & Ransford has added two life sciences lawyers to its partnership, effective from July 1.
Big Pharma
1 September 2022 New partner brings pharma and chemistry focus, and boosts the European firm’s Unified Patent Court team.
Big Pharma
9 February 2016 Law firm Carpmaels & Ransford has hired David Wilson and Jake Marshall as partners in the firm’s patent litigation and life sciences practices.
Big Pharma
25 June 2018 Carpmaels & Ransford has added two life sciences lawyers to its partnership, effective from July 1.
Big Pharma
1 September 2022 New partner brings pharma and chemistry focus, and boosts the European firm’s Unified Patent Court team.